Edgemoor Investment Advisors’s Novavax NVAX Stock Holding History

Edgemoor Investment Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,404	Closed	-$55K	–	151
2017 Q3	$55K	Buy	+2,404	New	+$53.8K	0.01%	144
2016 Q4	–	Sell	-750	Closed	-$31K	–	120
2016 Q3	$31K	Hold	750	–	–	﹤0.01%	119
2016 Q2	$109K	Hold	750	–	–	0.02%	118
2016 Q1	$77K	Hold	750	–	–	0.01%	120
2015 Q4	$126K	Hold	750	–	–	0.02%	137
2015 Q3	$106K	Hold	750	–	–	0.02%	143
2015 Q2	$167K	Hold	750	–	–	0.02%	138
2015 Q1	$124K	Hold	750	–	–	0.02%	135
2014 Q4	$89K	Hold	750	–	–	0.01%	135
2014 Q3	$63K	Hold	750	–	–	0.01%	134
2014 Q2	$69K	Hold	750	–	–	0.01%	137
2014 Q1	$68K	Buy	+750	New	+$83.8K	0.01%	125

Other funds holding NVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edgemoor Investment Advisors's NVAX Position: Q4 2017 in Review

Edgemoor Investment Advisors sold out of Novavax (NVAX) in Q4 2017, closing a stake of 2,404 shares — an estimated $55K sold.

Edgemoor Investment Advisors first reported a position in NVAX in Q1 2014 and held it in 12 quarters. The position peaked at $167K in Q2 2015. 134 funds tracked by Wall St. Rank hold NVAX as of Q4 2017.

Edgemoor Investment Advisors reported no remaining Novavax position as of Q4 2017 after selling out during the quarter.
Edgemoor Investment Advisors sold 2,404 Novavax shares in Q4 2017, an estimated $55K.
Edgemoor Investment Advisors first reported a position in Novavax in Q1 2014 and held it in 12 quarters.
Edgemoor Investment Advisors's Novavax position peaked at $167K in Q2 2015.
134 funds tracked by Wall St. Rank held Novavax as of Q4 2017.

Based on Edgemoor Investment Advisors's 13F filing for Q4 2017, filed 7 Feb 2018.